Entry Detail



General Information

Database ID:exR0261927
RNA Name:hsa-miR-27b-3p
RNA Type:miRNA
Chromosome:chr9
Starnd:+
Coordinate:
Start Site(bp):95085505End Site(bp):95085525
External Links:hsa-miR-27b-3p



Disease Information

Disease Name:Prostate Cancer
Disease Category:Cancers
MeSH ID:D011471
Type:Neoplasms/Digestive System Neoplasms
Alias:Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate



Expression Detail

GEO ID:GSE134266
Description:Deep sequencing identified serum extracellular vesicle delivered miR-181a-5p as an indicator for bone-metastatic prostate cancer (microarray)
Experimental Design:Cancer vs Control
Case Disease Type:Prostate Cancer
Case Disease SubType:Bone Metastatic Prostate Cancer
Case Sample:Bone Metastatic Prostate Cancer
Control Sample:Benign Prostatic Hyperplasia
Number of Case:8
Number of Control:9
Number of Samples:17





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
NUAK1
chr12
106063340
106140033
-
IDS
chrX
149476988
149521096
-
AEN
chr15
88621337
88632281
+
RTL10
chr22
19846138
19854896
-
SOX11
chr2
5692384
5701385
+
KCNK1
chr1
233614106
233672514
+
ALDH3A2
chr17
19648136
19685760
+
GIPC1
chr19
14477760
14496149
-
LASP1
chr17
38869859
38921770
+
LARP4B
chr10
806914
931705
-
DCTN4
chr5
150708440
150759109
-
TMX4
chr20
7977346
8019805
-
B4GALT3
chr1
161171310
161177968
-
GLTP
chr12
109850945
109880541
-
PLK2
chr5
58453982
58460139
-
URGCP
chr7
43875894
43926411
-
ONECUT2
chr18
57435374
57491298
+
ACER3
chr11
76860867
77026797
+
PRKX
chrX
3604340
3713649
-
LGALS8
chr1
236518000
236552981
+
CDR2
chr16
22345936
22437165
-
NRBP1
chr2
27427790
27442259
+
CANX
chr5
179678628
179731641
+
IRF4
chr6
391752
411443
+
INO80D
chr2
205993721
206086303
-
PPP1CC
chr12
110719680
110742939
-
TTYH3
chr7
2631986
2664802
+
IGF2BP3
chr7
23310209
23470491
-
KPNA6
chr1
32108056
32176563
+
STRBP
chr9
123109500
123268586
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000384
chr12
27867712
27877119
+
hsa_circ_0001247
chr22
46125304
46136418
+
hsa_circ_0000942
chr19
46020920
46021352
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010980.2
chr2
222317242
222318653
-
AC021092.1
chr19
44103007
44113183
-
AC022150.4
chr19
52650437
52653284
-
AC093010.3
chr3
114314501
114329714
-
AL050341.2
chr1
40256427
40257967
-
KCNQ1OT1
chr11
2608328
2699994
-
LINC01089
chr12
121795267
121803906
-
LINC02381
chr12
54126082
54147485
+
NEAT1
chr11
65422774
65445540
+
SDCBP2-AS1
chr20
1325405
1378735
+
SNHG22
chr18
49814023
49851059
+
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE134266
Sample Source:Blood
Source Fraction:Extracellular Vesicle
Platform:GPL25134
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2519
Sample treatment protocol:The blood was centrifuged at 2000 g for 10 min at 4 °C to extract the serum. The serum EV was extracted using Total Exosome Isolation Kit (from serum, Thermo fisher scientific).
RNA Extract protocol:Exosome Purification and RNA Isolation Kit (Norgen Biotek) was employed to purify EV and extract total RNA in EV consequentially.
RNA library preparation protocol:Sample tag and reagents are included in the hybrid need Agilent's micrornas Complete Labeling and Hyb Kit (p/n 5190-0456).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA